Esther Heijnen, MD, PhD

Clinical Franchise Leader, Vaccines
Janssen Vaccines & Prevention B.V.
Leiden, Zuid-Holland, Netherlands

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• 2321 - Long-term immunogenicity of Ad26.RSV.preF/RSV preF protein vaccine against RSV in a phase 2b study by age and risk level

  Saturday, October 22, 2022
  2:30 PM – 2:45 PM US ET